Technology
Health
Biotechnology

Savara

1,831

$2.24
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.09 (+4.19%) As of 10:32 AM EDT today
+$0.09 (+4.19%) Today

Why Robinhood?

You can buy or sell Savara and other stocks, options, ETFs, and crypto commission-free!

About SVRA

Savara Inc. Common Stock, also called Savara, is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Read More Its products include AeroVanc, Molgradex, GM-CSF, and Aironite. The company was founded on April 27, 2017 and is headquartered in Austin, TX.

CEO
Robert Norman Neville
Employees
39
Headquarters
Austin, Texas
Founded
2017
Market Cap
114.39M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
467.12K
High Today
$2.32
Low Today
$2.18
Open Price
$2.24
Volume
36.76K
52 Week High
$11.96
52 Week Low
$0.69

Collections

Technology
Health
Biotechnology
Medical
Pharmaceutical
2013 IPO
US
North America

SVRA Earnings

-$0.57
-$0.38
-$0.19
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 7, After Hours

People Also Bought

Inpixon

28,815

$1.28

+7.56%

Inpixon

28,815

$1.28

+7.56%

Onconova Therapeutics

26,295

$0.302

-5.60%

Titan Pharmaceuticals

36,056

$0.2711

+8.44%

Cassava Sciences

1,634

$4.16

-2.40%

You May Also Like

HHR
TPCO
CNTG
IDX
JPED
HBI
RUBY
VIXY
MITO
LADR
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy SVRA

Market Price$2.24
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Savara stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up